| Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model L Forgács, AM Borman, E Prépost, Z Tóth, G Kardos, R Kovács, A Szekely, ... Emerging microbes & infections 9 (1), 1160-1169, 2020 | 63 | 2020 |
| In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae Z Tóth, L Forgács, JB Locke, G Kardos, F Nagy, R Kovács, A Szekely, ... Journal of Antimicrobial Chemotherapy 74 (12), 3505-3510, 2019 | 60 | 2019 |
| Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms R Kovács, A Bozó, R Gesztelyi, M Domán, G Kardos, F Nagy, Z Tóth, ... International journal of antimicrobial agents 47 (4), 304-310, 2016 | 59 | 2016 |
| Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 S Devi, HT Kiesewalter, R Kovács, JC Frisvad, T Weber, TO Larsen, ... Synthetic and Systems Biotechnology 4 (3), 142-149, 2019 | 53 | 2019 |
| Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms R Kovács, L Majoros Journal of Fungi 6 (3), 99, 2020 | 48 | 2020 |
| Candida biofilm production is associated with higher mortality in patients with candidaemia E Vitális, F Nagy, Z Tóth, L Forgács, A Bozó, G Kardos, L Majoros, ... Mycoses 63 (4), 352-360, 2020 | 48 | 2020 |
| In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris F Nagy, E Vitális, Á Jakab, AM Borman, L Forgács, Z Tóth, L Majoros, ... Frontiers in microbiology 11, 957, 2020 | 47 | 2020 |
| Farnesol increases the activity of echinocandins against Candida auris biofilms F Nagy, Z Tóth, L Daróczi, A Székely, AM Borman, L Majoros, R Kovács Medical mycology 58 (3), 404-407, 2020 | 40 | 2020 |
| The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model A Bozó, M Domán, L Majoros, G Kardos, I Varga, R Kovács Journal of Microbiology 54, 753-760, 2016 | 40 | 2016 |
| Comparative biocompatibility and antimicrobial studies of sorbic acid derivates D Nemes, R Kovács, F Nagy, Z Tóth, P Herczegh, A Borbás, V Kelemen, ... European Journal of Pharmaceutical Sciences 143, 105162, 2020 | 37 | 2020 |
| Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms R Kovács, F Nagy, Z Tóth, A Bozó, B Balázs, L Majoros Letters in applied microbiology 69 (4), 271-278, 2019 | 34 | 2019 |
| Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts G Spengler, M Gajdács, MG Donadu, M Usai, M Marchetti, M Ferrari, ... Microorganisms 10 (4), 758, 2022 | 33 | 2022 |
| Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence … R Kovács, Z Tóth, JB Locke, L Forgács, G Kardos, F Nagy, AM Borman, ... Microorganisms 9 (4), 863, 2021 | 30 | 2021 |
| Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans R Földi, R Kovács, R Gesztelyi, G Kardos, R Berényi, B Juhász, J Szilágyi, ... Mycopathologia 174, 311-318, 2012 | 30 | 2012 |
| In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis R Kovács, J Holzknecht, Z Hargitai, C Papp, A Farkas, A Borics, L Tóth, ... Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac. 01777-18, 2019 | 29 | 2019 |
| Interaction between different pharmaceutical excipients in liquid dosage forms—Assessment of cytotoxicity and antimicrobial activity D Nemes, R Kovács, F Nagy, M Mező, N Poczok, Z Ujhelyi, Á Pető, ... Molecules 23 (7), 1827, 2018 | 29 | 2018 |
| Physiological and transcriptional responses of Candida parapsilosis to exogenous tyrosol Á Jakab, Z Tóth, F Nagy, D Nemes, I Bácskay, G Kardos, T Emri, I Pócsi, ... Applied and Environmental Microbiology 85 (20), e01388-19, 2019 | 28 | 2019 |
| Serum interleukin-6 levels in murine models of Candida albicans infection R Kovács, A Czudar, L Horváth, L Szakács, L Majoros, J Kónya Acta Microbiologica et Immunologica Hungarica 61 (1), 61-69, 2014 | 25 | 2014 |
| Killing rates exerted by caspofungin in 50% serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua R Kovacs, R Gesztelyi, R Berenyi, M Doman, G Kardos, B Juhasz, ... Journal of medical microbiology 63 (2), 186-194, 2014 | 25 | 2014 |
| Manufacturing and examination of vaginal drug delivery system by FDM 3D printing P Arany, I Papp, M Zichar, G Regdon Jr, M Béres, M Szalóki, R Kovács, ... Pharmaceutics 13 (10), 1714, 2021 | 24 | 2021 |
Majoros LászlóDebreceni EgyetemE-mailová adresa ověřena na: med.unideb.hu
